PD-1-specific “Blocking” antibodies that deplete PD-1+ T cells present an inconvenient variable in preclinical immunotherapy experiments

Fanny Polesso, Michael W. Munks, Katherine H. Rott, Savannah Smart, Ann B. Hill, Amy E. Moran

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'PD-1-specific “Blocking” antibodies that deplete PD-1+ T cells present an inconvenient variable in preclinical immunotherapy experiments'. Together they form a unique fingerprint.

Medicine & Life Sciences